Jie Luo

Title: Innovations by Jie Luo in Immunotherapy

Introduction

Jie Luo is an accomplished inventor based in Dresher, PA (US). He has made significant contributions to the field of immunotherapy, particularly in the treatment of myasthenia gravis. His innovative work has led to the development of a unique vaccine composition aimed at addressing this challenging condition.

Latest Patents

Jie Luo holds a patent for "Acetylcholine receptor-specific immunosuppressive compositions and methods of treatment of myasthenia gravis." This patent describes a vaccine composition that includes two or three acetylcholine receptor (AChR) subunit constructs along with an adjuvant. The AChR subunit constructs may include various subunits such as AChR α1, AChR β1, AChR γ, AChR δ, or AChR ε. The invention also outlines a method for treating myasthenia gravis by administering this vaccine composition to patients in need.

Career Highlights

Jie Luo is affiliated with the University of Pennsylvania, where he continues to advance research in immunotherapy. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from myasthenia gravis. With 1 patent to his name, he is recognized for his innovative approach to medical treatment.

Collaborations

Jie Luo collaborates with Jon Lindstrom, a fellow researcher, to further explore the implications of his inventions in the field of immunotherapy.

Conclusion

Jie Luo's contributions to the field of immunotherapy, particularly through his patent on acetylcholine receptor-specific compositions, highlight his role as an innovative inventor. His work at the University of Pennsylvania continues to pave the way for advancements in the treatment of myasthenia gravis.